| AI | Artificial Intelligence |
| ApoB | Apolipoprotein B |
| ADMA | Asymmetric dimethylarginine |
| AMPK | AMP-activated protein kinase |
| ATMs | Adipose tissue macrophages |
| BMI | Body mass index |
| CAC | Coronary artery calcium |
| CAD | Coronary artery disease |
| cAMP | Cyclic adenosine monophosphate |
| CIMT | Carotid intima media thickness |
| CRP | C-reactive protein |
| CT | Computed tomography |
| CVD | Cardiovascular disease |
| DPP-4 | Dipeptidil peptidase-4 |
| Endo PAT | Endothelial peripheral arterial tonometry |
| eNOS | Endothelial nitric oxide synthase |
| FFAs | Free fatty acids |
| FMD | Flow-mediated dilation |
| GIP | Glucose-dependent insulinotropic polypeptide |
| GLP-1 RAs | Glucagon-like peptide-1 receptor agonists |
| HFpEF | Heart Failure with preserved ejection fraction |
| hs-CRP | high-sensitivity C-reactive protein |
| IL | Interleukin |
| Lp(a) | Lipoprotein(a) |
| LPL | Lipoprotein lipase |
| MCP-1 | Monocyte Chemoattractant Protein-1 |
| miRNAs | Micro ribonucleic acids |
| MRI | Magnetic resonance imaging |
| NO | Nitric oxide |
| NOX2 | NADPH oxdase 2 |
| PAD | Peripheral arterial disease |
| PET | Positron emission tomography |
| PKA | Protein kinase A |
| PVAT | Perivascular adipose tissue |
| RAAS | Renin–angiotensin–aldosterone system |
| ROS | Reactive oxygen species |
| SAA | Serum amyloid A |
| SGLT2is | Sodium-Glucose Cotransporter-2 inhibitors |
| sICAM-1 | Soluble Intercellular Adhesion Molecule-1 |
| sVCAM-1 | Soluble Vascular Cell Adhesion Molecule-1 |
| T2DM | Type 2 Diabetes Mellitus |
| TNF-α | Tumor Necrosis Factor-α |
| WHO | World Health Organization |